摘要
目的:研究脆性糖尿病(DM)患者行实时动态胰岛素泵(3C)、动态血糖监测系统(GGMS)治疗效果。方法:样本采集本院2019年8月~2020年8月收治的80例脆性DM患者为研究对象,采用双盲法分为对照组(胰岛素泵-2C,n=40)和观察组(3C方案,n=40),比较两组血糖指标、临床指标、血糖波动及不良反应。结果:治疗前比较2组血糖波动无差异,治疗后2组比较不良反应发生率也无差异,P>0.05;治疗后与对照组比较,观察组FBG、2hPG及HbA1c指标更低;与对照组比较,观察组MBG、MAGE、FBG、ACU10、ACU3.9指标更低,低血糖次数、胰岛素用量更少,血糖达标时间更短,P<0.05。结论:3C方案治疗此病能控制血糖波动、减少低血糖。
Objective:To study the effect of real-time dynamic insulin pump(3C)and dynamic blood glucose monitoring system(GGMS)in patients with fragile diabetes(DM).Methods:Samples were collected from 80 patients with fragile DM admitted to our hospital from August 2019 to August 2020 as the research objects.The“double-blind method”was divided into control group(insulin pump-2C,n=40)and observation group(3C plan),n=40),comparison of blood glucose indicators,clinical indicators,blood glucose fluctuations and adverse reactions between the two groups.Results:There was no difference in blood glucose fluctuation between the two groups before treatment,and there was no difference in the incidence of adverse reactions between the two groups after treatment,P>0.05;After treatment,compared with the control group,the observation group had lower FBG,2h PG and HbA1c indicators;Compared with the control group In comparison,the observation group had lower MBG,MAGE,FBG,ACU10,ACU3.9 indicators,fewer hypoglycemia times,fewer insulin dosages,and shorter blood glucose compliance time,P<0.05.Conclusion:The 3C regimen can control blood glucose fluctuations and reduce hypoglycemia in the treatment of this disease.
作者
吴苏凝
WU Su-ning(Department of Endocrinology,Yingkou Central Hospital,Liaoning Province,Liaoning Yingkou 115000)
出处
《中国医疗器械信息》
2023年第8期141-143,共3页
China Medical Device Information
关键词
脆性糖尿病
动态胰岛素泵
动脉血糖监测
疗效
血糖波动
不良反应
fragile diabetes
dynamic insulin pump
arterial blood glucose monitoring
curative effect
blood glucose fluctuation
adverse reactions